$SENS
Senseonics Holdings, Inc.

2020 Q4 Form 10-Q Financial Statement

#000155837020013382 Filed on November 09, 2020

View on sec.gov

Income Statement

Concept 2020 Q4 2020 Q3 2019 Q3
Revenue $3.885M $767.0K $4.319M
YoY Change -56.61% -82.24% -16.27%
Cost Of Revenue $1.309M -$68.00K $7.659M
YoY Change -92.39% -100.89% -1.07%
Gross Profit $2.576M $835.0K -$3.340M
YoY Change -131.25% -125.0% 29.26%
Gross Profit Margin 66.31% 108.87% -77.33%
Selling, General & Admin $8.195M $8.735M $16.95M
YoY Change -51.48% -48.46% 30.48%
% of Gross Profit 318.13% 1046.11%
Research & Development $4.568M $11.08M
YoY Change -58.76% 49.64%
% of Gross Profit 547.07%
Depreciation & Amortization $288.0K $284.0K -$83.00K
YoY Change -56.76% -442.17% -206.41%
% of Gross Profit 11.18% 34.01%
Operating Expenses $12.88M $13.30M $28.02M
YoY Change -51.63% -52.53% 37.43%
Operating Profit -$10.31M -$12.47M -$31.36M
YoY Change -70.45% -60.25% 36.51%
Interest Expense -$76.04M $3.632M $12.90M
YoY Change 8560.14% -71.85% -245.56%
% of Operating Profit
Other Income/Expense, Net -$12.30M -$10.96M $11.87M
YoY Change -8639.58% -192.37% -27693.02%
Pretax Income -$101.6M -$23.43M -$19.50M
YoY Change 185.39% 20.15% -38.84%
Income Tax $0.00 $0.00
% Of Pretax Income
Net Earnings -$101.6M -$23.43M -$19.50M
YoY Change 185.39% 20.15% -38.84%
Net Earnings / Revenue -2616.01% -3054.5% -451.47%
Basic Earnings Per Share -$0.10
Diluted Earnings Per Share -$405.1K -$0.10 -$98.87K
COMMON SHARES
Basic Shares Outstanding 245.7M 236.5M
Diluted Shares Outstanding 236.5M

Balance Sheet

Concept 2020 Q4 2020 Q3 2019 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $18.01M $26.19M $130.6M
YoY Change -81.23% -79.94% -19.9%
Cash & Equivalents $18.01M $26.19M $130.6M
Short-Term Investments $0.00
Other Short-Term Assets $3.974M $4.788M $4.862M
YoY Change -11.92% -1.52% 2.94%
Inventory $5.281M $4.284M $19.86M
Prepaid Expenses
Receivables $2.986M $501.0K $6.268M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $30.25M $35.77M $161.6M
YoY Change -76.33% -77.86% -11.15%
LONG-TERM ASSETS
Property, Plant & Equipment $1.557M $1.665M $5.353M
YoY Change -22.19% -68.9% 294.18%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $1.886M $4.224M
YoY Change
Other Assets $101.0K $2.409M $121.0K
YoY Change -96.68% 1890.91% 1.68%
Total Long-Term Assets $5.672M $8.298M $5.474M
YoY Change 12.47% 51.59% 270.62%
TOTAL ASSETS
Total Short-Term Assets $30.25M $35.77M $161.6M
Total Long-Term Assets $5.672M $8.298M $5.474M
Total Assets $35.92M $44.06M $167.0M
YoY Change -72.95% -73.62% -8.88%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.762M $949.0K $3.253M
YoY Change -58.88% -70.83% -15.94%
Accrued Expenses $11.52M $9.100M $18.66M
YoY Change -38.05% -51.23% 130.69%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $3.202M $0.00 $0.00
YoY Change -96.91% -100.0%
Total Short-Term Liabilities $16.64M $10.10M $21.96M
YoY Change -86.87% -53.99% -3.37%
LONG-TERM LIABILITIES
Long-Term Debt $57.22M $59.65M $90.29M
YoY Change 384.88% -33.94% 112.52%
Other Long-Term Liabilities $1.483M $1.693M $29.45M
YoY Change -34.9% -94.25% -29.06%
Total Long-Term Liabilities $1.483M $1.693M $119.7M
YoY Change -34.9% -98.59% 42.55%
TOTAL LIABILITIES
Total Short-Term Liabilities $16.64M $10.10M $21.96M
Total Long-Term Liabilities $1.483M $1.693M $119.7M
Total Liabilities $177.2M $96.03M $141.7M
YoY Change 25.27% -32.23% 32.77%
SHAREHOLDERS EQUITY
Retained Earnings -$648.5M -$546.9M
YoY Change 37.01%
Common Stock $266.0K $244.0K
YoY Change 31.03%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$144.1M -$54.78M $25.35M
YoY Change
Total Liabilities & Shareholders Equity $35.92M $44.06M $167.0M
YoY Change -72.95% -73.62% -8.88%

Cashflow Statement

Concept 2020 Q4 2020 Q3 2019 Q3
OPERATING ACTIVITIES
Net Income -$101.6M -$23.43M -$19.50M
YoY Change 185.39% 20.15% -38.84%
Depreciation, Depletion And Amortization $288.0K $284.0K -$83.00K
YoY Change -56.76% -442.17% -206.41%
Cash From Operating Activities -$8.248M -$13.40M -$35.63M
YoY Change -76.13% -62.4% 33.31%
INVESTING ACTIVITIES
Capital Expenditures $0.00 -$3.000K -$215.0K
YoY Change -100.0% -98.6% -57.26%
Acquisitions
YoY Change
Other Investing Activities $0.00
YoY Change -100.0%
Cash From Investing Activities $0.00 -$3.000K -$215.0K
YoY Change -100.0% -98.6% -114.41%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $100.0K
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 61.00K 18.20M 101.1M
YoY Change 369.23% -82.01% -6181.18%
NET CHANGE
Cash From Operating Activities -8.248M -13.40M -35.63M
Cash From Investing Activities 0.000 -3.000K -215.0K
Cash From Financing Activities 61.00K 18.20M 101.1M
Net Change In Cash -8.187M 4.795M 65.28M
YoY Change -76.37% -92.66% -342.71%
FREE CASH FLOW
Cash From Operating Activities -$8.248M -$13.40M -$35.63M
Capital Expenditures $0.00 -$3.000K -$215.0K
Free Cash Flow -$8.248M -$13.39M -$35.42M
YoY Change -76.07% -62.18% 35.05%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2020Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2019Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2020Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
244238638
CY2019Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
203452812
dei Entity Registrant Name
EntityRegistrantName
SENSEONICS HOLDINGS, INC.
dei Entity Central Index Key
EntityCentralIndexKey
0001616543
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2020
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Amendment Flag
AmendmentFlag
false
CY2020Q3 us-gaap Temporary Equity Shares Outstanding
TemporaryEquitySharesOutstanding
0
CY2019Q4 us-gaap Temporary Equity Shares Outstanding
TemporaryEquitySharesOutstanding
0
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2020-09-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-37717
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
47-1210911
dei Entity Address Address Line1
EntityAddressAddressLine1
20451 Seneca Meadows Parkway
dei Entity Address City Or Town
EntityAddressCityOrTown
Germantown
dei Entity Address State Or Province
EntityAddressStateOrProvince
MD
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
20876-7005
dei City Area Code
CityAreaCode
301
dei Local Phone Number
LocalPhoneNumber
515-7260
dei Security12b Title
Security12bTitle
Common Stock, $0.001 par value
dei Trading Symbol
TradingSymbol
SENS
dei Security Exchange Name
SecurityExchangeName
NYSEAMER
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2020Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
245666611
CY2020Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
26192000
CY2019Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
95938000
CY2020Q3 us-gaap Restricted Cash Current
RestrictedCashCurrent
200000
CY2020Q3 us-gaap Accounts Receivable Net
AccountsReceivableNet
250000
CY2019Q4 us-gaap Accounts Receivable Net
AccountsReceivableNet
3239000
CY2020Q3 us-gaap Accounts Receivable Related Parties Current
AccountsReceivableRelatedPartiesCurrent
251000
CY2019Q4 us-gaap Accounts Receivable Related Parties Current
AccountsReceivableRelatedPartiesCurrent
7140000
CY2020Q3 us-gaap Inventory Net
InventoryNet
4284000
CY2019Q4 us-gaap Inventory Net
InventoryNet
16929000
CY2020Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
4588000
CY2019Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
4512000
CY2020Q3 us-gaap Assets Current
AssetsCurrent
35765000
CY2019Q4 us-gaap Assets Current
AssetsCurrent
127758000
CY2020Q3 us-gaap Derivative Assets Noncurrent
DerivativeAssetsNoncurrent
4224000
CY2020Q3 sens Deposits And Other Assets Noncurrent
DepositsAndOtherAssetsNoncurrent
2409000
CY2019Q4 sens Deposits And Other Assets Noncurrent
DepositsAndOtherAssetsNoncurrent
3042000
CY2020Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1665000
CY2019Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2001000
CY2020Q3 us-gaap Assets
Assets
44063000
CY2019Q4 us-gaap Assets
Assets
132801000
CY2020Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
949000
CY2019Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
4285000
CY2020Q3 sens Accrued Liabilities And Other Liabilities Current
AccruedLiabilitiesAndOtherLiabilitiesCurrent
9153000
CY2019Q4 sens Accrued Liabilities And Other Liabilities Current
AccruedLiabilitiesAndOtherLiabilitiesCurrent
18636000
CY2019Q4 us-gaap Notes Payable To Bank Current
NotesPayableToBankCurrent
43434000
CY2019Q4 us-gaap Convertible Subordinated Debt Current
ConvertibleSubordinatedDebtCurrent
60353000
CY2020Q3 us-gaap Liabilities Current
LiabilitiesCurrent
10102000
CY2019Q4 us-gaap Liabilities Current
LiabilitiesCurrent
126708000
CY2020Q3 us-gaap Long Term Debt
LongTermDebt
59649000
CY2019Q4 us-gaap Long Term Debt
LongTermDebt
11800000
CY2020Q3 us-gaap Derivative Liabilities Noncurrent
DerivativeLiabilitiesNoncurrent
24590000
CY2019Q4 us-gaap Derivative Liabilities Noncurrent
DerivativeLiabilitiesNoncurrent
664000
CY2020Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
1693000
CY2019Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
2278000
CY2020Q3 us-gaap Liabilities
Liabilities
96034000
CY2019Q4 us-gaap Liabilities
Liabilities
141450000
CY2020Q3 us-gaap Temporary Equity Par Or Stated Value Per Share
TemporaryEquityParOrStatedValuePerShare
0.001
CY2019Q4 us-gaap Temporary Equity Par Or Stated Value Per Share
TemporaryEquityParOrStatedValuePerShare
0.001
CY2020Q3 us-gaap Temporary Equity Shares Authorized
TemporaryEquitySharesAuthorized
3000
CY2019Q4 us-gaap Temporary Equity Shares Authorized
TemporaryEquitySharesAuthorized
3000
CY2020Q3 us-gaap Temporary Equity Shares Issued
TemporaryEquitySharesIssued
0
CY2019Q4 us-gaap Temporary Equity Shares Issued
TemporaryEquitySharesIssued
0
CY2020Q3 us-gaap Temporary Equity Value Excluding Additional Paid In Capital
TemporaryEquityValueExcludingAdditionalPaidInCapital
2811000
CY2020Q3 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
2811000
CY2020Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2019Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2020Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
450000000
CY2019Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
450000000
CY2020Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
244238638
CY2019Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
203452812
CY2020Q3 us-gaap Common Stock Value
CommonStockValue
244000
CY2019Q4 us-gaap Common Stock Value
CommonStockValue
203000
CY2020Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
491853000
CY2019Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
464491000
CY2020Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-546879000
CY2019Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-473343000
CY2020Q3 us-gaap Stockholders Equity
StockholdersEquity
-54782000
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
-8649000
CY2020Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
44063000
CY2019Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
132801000
CY2020Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
514000
CY2019Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
959000
CY2020Q3 sens Cost Of Goods And Services Sold Net
CostOfGoodsAndServicesSoldNet
-68000
CY2019Q3 sens Cost Of Goods And Services Sold Net
CostOfGoodsAndServicesSoldNet
7659000
sens Cost Of Goods And Services Sold Net
CostOfGoodsAndServicesSoldNet
21006000
sens Cost Of Goods And Services Sold Net
CostOfGoodsAndServicesSoldNet
23552000
CY2020Q3 us-gaap Gross Profit
GrossProfit
835000
CY2019Q3 us-gaap Gross Profit
GrossProfit
-3340000
us-gaap Gross Profit
GrossProfit
-19942000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
761000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
3678000
CY2020Q3 us-gaap Revenue From Related Parties
RevenueFromRelatedParties
253000
CY2019Q3 us-gaap Revenue From Related Parties
RevenueFromRelatedParties
3360000
us-gaap Revenue From Related Parties
RevenueFromRelatedParties
303000
us-gaap Revenue From Related Parties
RevenueFromRelatedParties
8671000
CY2020Q3 us-gaap Revenues
Revenues
767000
CY2019Q3 us-gaap Revenues
Revenues
4319000
us-gaap Revenues
Revenues
1064000
us-gaap Revenues
Revenues
12349000
us-gaap Gross Profit
GrossProfit
-11203000
CY2020Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
3234000
CY2019Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
11560000
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
17521000
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
38573000
CY2020Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
4568000
CY2019Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
11076000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
15726000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
28688000
CY2020Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
5501000
CY2019Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
5388000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
15635000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
17321000
CY2020Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-12468000
CY2019Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-31364000
us-gaap Operating Income Loss
OperatingIncomeLoss
-68824000
us-gaap Operating Income Loss
OperatingIncomeLoss
-95785000
CY2020Q3 us-gaap Investment Income Interest And Dividend
InvestmentIncomeInterestAndDividend
1000
CY2019Q3 us-gaap Investment Income Interest And Dividend
InvestmentIncomeInterestAndDividend
519000
us-gaap Investment Income Interest And Dividend
InvestmentIncomeInterestAndDividend
173000
us-gaap Investment Income Interest And Dividend
InvestmentIncomeInterestAndDividend
1556000
CY2020Q3 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-9527000
CY2019Q3 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-398000
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-20458000
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-398000
CY2020Q3 sens Interest Expense Excluding Debt Issuance Costs
InterestExpenseExcludingDebtIssuanceCosts
3632000
CY2019Q3 sens Interest Expense Excluding Debt Issuance Costs
InterestExpenseExcludingDebtIssuanceCosts
3460000
sens Interest Expense Excluding Debt Issuance Costs
InterestExpenseExcludingDebtIssuanceCosts
11560000
sens Interest Expense Excluding Debt Issuance Costs
InterestExpenseExcludingDebtIssuanceCosts
7459000
CY2020Q3 us-gaap Debt Related Commitment Fees And Debt Issuance Costs
DebtRelatedCommitmentFeesAndDebtIssuanceCosts
931000
CY2019Q3 us-gaap Debt Related Commitment Fees And Debt Issuance Costs
DebtRelatedCommitmentFeesAndDebtIssuanceCosts
3344000
us-gaap Debt Related Commitment Fees And Debt Issuance Costs
DebtRelatedCommitmentFeesAndDebtIssuanceCosts
1216000
us-gaap Debt Related Commitment Fees And Debt Issuance Costs
DebtRelatedCommitmentFeesAndDebtIssuanceCosts
3344000
CY2020Q3 us-gaap Fair Value Net Derivative Asset Liability Measured On Recurring Basis Change In Unrealized Gain Loss
FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisChangeInUnrealizedGainLoss
3520000
CY2019Q3 us-gaap Fair Value Net Derivative Asset Liability Measured On Recurring Basis Change In Unrealized Gain Loss
FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisChangeInUnrealizedGainLoss
19186000
us-gaap Fair Value Net Derivative Asset Liability Measured On Recurring Basis Change In Unrealized Gain Loss
FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisChangeInUnrealizedGainLoss
29069000
us-gaap Fair Value Net Derivative Asset Liability Measured On Recurring Basis Change In Unrealized Gain Loss
FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisChangeInUnrealizedGainLoss
26147000
CY2020Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-391000
CY2019Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-638000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-720000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-655000
CY2020Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-10960000
CY2019Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
11865000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-4712000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
15847000
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
-23428000
CY2019Q3 us-gaap Net Income Loss
NetIncomeLoss
-19499000
us-gaap Net Income Loss
NetIncomeLoss
-73536000
us-gaap Net Income Loss
NetIncomeLoss
-79938000
CY2020Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-23428000
CY2019Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-19499000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-73536000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-79938000
CY2020Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.10
CY2019Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.10
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.33
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.43
CY2020Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
236519812
CY2019Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
197223419
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
220250060
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
183804257
CY2019Q2 us-gaap Stockholders Equity
StockholdersEquity
15172000
CY2019Q3 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
26757000
CY2019Q3 sens Adjustments To Additional Paid In Capital Share Based Compensation Stock Options And Restricted Stock Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsAndRestrictedStockRequisiteServicePeriodRecognition
2194000
CY2019Q3 us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
723000
CY2019Q3 us-gaap Net Income Loss
NetIncomeLoss
-19499000
CY2019Q3 us-gaap Stockholders Equity
StockholdersEquity
25347000
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
71261000
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
26757000
us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
93000
sens Adjustments To Additional Paid In Capital Share Based Compensation Stock Options And Restricted Stock Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsAndRestrictedStockRequisiteServicePeriodRecognition
6451000
us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
723000
us-gaap Net Income Loss
NetIncomeLoss
-79938000
CY2019Q3 us-gaap Stockholders Equity
StockholdersEquity
25347000
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
-39605000
CY2020Q3 sens Exercise Of Stock Options Vesting Of Rs Us And Espp Purchases
ExerciseOfStockOptionsVestingOfRSUsAndESPPPurchases
77000
CY2020Q3 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
5871000
CY2020Q3 sens Adjustments To Additional Paid In Capital Share Based Compensation Stock Options And Restricted Stock Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsAndRestrictedStockRequisiteServicePeriodRecognition
2303000
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
-23428000
CY2020Q3 us-gaap Stockholders Equity
StockholdersEquity
-54782000
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
-8649000
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
-86000
sens Exercise Of Stock Options Vesting Of Rs Us And Espp Purchases
ExerciseOfStockOptionsVestingOfRSUsAndESPPPurchases
575000
us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
20121000
sens Adjustments To Additional Paid In Capital Share Based Compensation Stock Options And Restricted Stock Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsAndRestrictedStockRequisiteServicePeriodRecognition
5581000
us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
1212000
us-gaap Net Income Loss
NetIncomeLoss
-73536000
CY2020Q3 us-gaap Stockholders Equity
StockholdersEquity
-54782000
us-gaap Profit Loss
ProfitLoss
-73536000
us-gaap Profit Loss
ProfitLoss
-79938000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
853000
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
7200000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
335000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-1154000
sens Increase Decrease In Accrued Liabilities And Other Current Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherCurrentLiabilities
-8608000
sens Increase Decrease In Accrued Liabilities And Other Current Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherCurrentLiabilities
3998000
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
6798000
sens Gains Losses On Extinguishment Of Debt And Debt Modification Fees
GainsLossesOnExtinguishmentOfDebtAndDebtModificationFees
-20458000
sens Fair Value Adjustment Derivative Liability
FairValueAdjustmentDerivativeLiability
-29069000
sens Fair Value Adjustment Derivative Liability
FairValueAdjustmentDerivativeLiability
-26147000
us-gaap Share Based Compensation
ShareBasedCompensation
5581000
us-gaap Share Based Compensation
ShareBasedCompensation
6452000
us-gaap Inventory Write Down
InventoryWriteDown
9441000
us-gaap Inventory Write Down
InventoryWriteDown
2077000
sens Noncash Lease Expense
NoncashLeaseExpense
336000
us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
-181000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-9880000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-829000
sens Increase Decrease In Prepaid Expense And Other Current Assets
IncreaseDecreaseInPrepaidExpenseAndOtherCurrentAssets
77000
sens Increase Decrease In Prepaid Expense And Other Current Assets
IncreaseDecreaseInPrepaidExpenseAndOtherCurrentAssets
877000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-3204000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
11708000
sens Increase Decrease In Deposit Assets And Other Assets
IncreaseDecreaseInDepositAssetsAndOtherAssets
-117000
sens Increase Decrease In Deposit Assets And Other Assets
IncreaseDecreaseInDepositAssetsAndOtherAssets
4000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-3336000
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-628000
us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
-877000
us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
-908000
sens Increase Decrease In Operating Lease Liabilities
IncreaseDecreaseInOperatingLeaseLiabilities
-586000
us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
947000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-59174000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-101486000
us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
181000
us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
951000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-181000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-951000
sens Proceeds From Issuance Of Common Stock Net
ProceedsFromIssuanceOfCommonStockNet
-87000
sens Proceeds From Issuance Of Common Stock Net
ProceedsFromIssuanceOfCommonStockNet
26757000
sens Proceeds From Exercise Of Stock Options And Espp Purchase
ProceedsFromExerciseOfStockOptionsAndESPPPurchase
576000
sens Proceeds From Exercise Of Stock Options And Espp Purchase
ProceedsFromExerciseOfStockOptionsAndESPPPurchase
94000
us-gaap Proceeds From Issuance Of Debt
ProceedsFromIssuanceOfDebt
55971000
us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
77699000
us-gaap Proceeds From Debt Net Of Issuance Costs
ProceedsFromDebtNetOfIssuanceCosts
42951000
us-gaap Proceeds From Issuance Of Warrants
ProceedsFromIssuanceOfWarrants
723000
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
66050000
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
15000000
us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
601000
us-gaap Repayments Of Convertible Debt
RepaymentsOfConvertibleDebt
37000000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-10191000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
96224000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-69546000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-6213000
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
95938000
CY2018Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
136793000
us-gaap Interest Paid Net
InterestPaidNet
5600000
us-gaap Interest Paid Net
InterestPaidNet
4200000
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
182000
us-gaap Stock Issued1
StockIssued1
300000
us-gaap Notes Reduction
NotesReduction
24000000
us-gaap Notes Issued1
NotesIssued1
15675000
CY2020Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
26392000
CY2019Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
130580000
us-gaap Net Income Loss
NetIncomeLoss
-73500000
CY2020Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-546900000
us-gaap Use Of Estimates
UseOfEstimates
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt;"><span style="font-style:italic;font-weight:bold;">Use of Estimates</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:36pt;margin:0pt;">The preparation of consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the reported amounts of revenue and expenses during the reporting period. In the accompanying unaudited consolidated financial statements, </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt;">estimates are used for, but not limited to, stock-based compensation, recoverability of long-lived assets, deferred taxes and valuation allowances, derivative assets and liabilities, obsolete inventory, warranty obligations, variable consideration related to revenue, depreciable lives of property and equipment, and accruals for clinical study costs, which are accrued based on estimates of work performed under contract. The Company considered COVID-19 related impacts to its estimates, as appropriate, within its unaudited condensed consolidated financial statements and there may be changes to those estimates in future periods due to the uncertainties surrounding the severity and duration of the COVID-19 pandemic. Actual results could differ from those estimates; however, management does not believe that such differences would be material.</p>
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1
CY2019 us-gaap Standard Product Warranty Accrual Warranties Issued
StandardProductWarrantyAccrualWarrantiesIssued
3296000
us-gaap Standard Product Warranty Accrual Payments
StandardProductWarrantyAccrualPayments
1211000
CY2019 us-gaap Standard Product Warranty Accrual Payments
StandardProductWarrantyAccrualPayments
1915000
CY2020Q3 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
1090000
CY2020Q3 us-gaap Cash
Cash
26189000
CY2019Q4 us-gaap Cash
Cash
38043000
CY2020Q3 us-gaap Money Market Funds At Carrying Value
MoneyMarketFundsAtCarryingValue
3000
CY2019Q4 us-gaap Money Market Funds At Carrying Value
MoneyMarketFundsAtCarryingValue
37769000
CY2019Q4 us-gaap Commercial Paper At Carrying Value
CommercialPaperAtCarryingValue
13870000
CY2019Q4 us-gaap Asset Backed Securities At Carrying Value
AssetBackedSecuritiesAtCarryingValue
6256000
CY2020Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
26192000
CY2019Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
95938000
CY2019Q4 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
2197000
sens Payment Period
PaymentPeriod
P60D
sens Patient Fee Basis To Determine Customer Reimbursement
PatientFeeBasisToDetermineCustomerReimbursement
99
sens Number Of Geographical Markets
NumberOfGeographicalMarkets
2
CY2019Q3 sens Number Of Geographical Markets
NumberOfGeographicalMarkets
2
sens Number Of Geographical Markets
NumberOfGeographicalMarkets
2
CY2020Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
26192000
CY2019Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
95938000
CY2020Q3 us-gaap Restricted Cash Current
RestrictedCashCurrent
200000
CY2020Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
26392000
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
95938000
us-gaap Tangible Asset Impairment Charges
TangibleAssetImpairmentCharges
200000
us-gaap Guarantees Indemnifications And Warranties Policies
GuaranteesIndemnificationsAndWarrantiesPolicies
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:14pt 0pt 0pt 0pt;"><span style="font-style:italic;font-weight:bold;">Warranty Obligation</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:1.19;text-indent:36pt;margin:14pt 0pt 0pt 0pt;"><span style="font-size:10pt;">The Company provides a warranty of </span><span style="font-size:10pt;">one year</span><span style="font-size:10pt;"> on its smart transmitters. Additionally, the Company may also replace Eversense system components that do not function in accordance with the product specifications. Estimated replacement costs are recorded at the time of shipment as a charge to cost of sales in the consolidated statement of operations and are developed by analyzing product performance data and historical replacement experience, including comparing actual return management authorizations to revenue.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:36pt;margin:14pt 0pt 0pt 0pt;">At September 30, 2020 and December 31, 2019, the warranty reserve was $1.1 million and $2.2 million, respectively. The decrease in warranty reserve balance was attributable to the decrease in warranty provisions during the period as a result of the temporary suspension of commercial sales of Eversense. The following table provides a reconciliation of the change in estimated warranty liabilities as of September 30, 2020 and December 31, 2019 (in thousands):</p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;margin-bottom:5pt;margin-top:5pt;visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:65.88%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:0pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:middle;white-space:nowrap;width:2.88%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:50%;transform:translate(0,-50%);width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:0pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.69%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:0pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:12.9%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:0pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:middle;white-space:nowrap;width:2.88%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:50%;transform:translate(0,-50%);width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:0pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.69%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:0pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:12.05%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:0pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:middle;white-space:nowrap;width:65.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0.05pt 0pt 0.05pt 0pt;"><span style="margin-bottom:0pt;visibility:hidden;">​</span></p></td><td style="vertical-align:middle;white-space:nowrap;width:2.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><span style="margin-bottom:0pt;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:14.59%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">September 30, </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;margin-bottom:0pt;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December 31,</b></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:65.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-style:italic;margin-bottom:0pt;visibility:hidden;">​</span></p></td><td style="vertical-align:middle;white-space:nowrap;width:2.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0.05pt 0pt 0.05pt 0pt;">    </p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:14.59%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2020</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;">    </p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.75%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2019</b></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:65.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0.05pt 0pt 0.05pt 0pt;">Balance at beginning of the year</p></td><td style="background-color:#cceeff;vertical-align:middle;white-space:nowrap;width:2.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0.05pt 0pt 0.05pt 0pt;"><span style="margin-bottom:0pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0.05pt 0pt 0.05pt 0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:12.9%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> 2,197</p></td><td style="background-color:#cceeff;vertical-align:middle;white-space:nowrap;width:2.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0.05pt 0pt 0.05pt 0pt;"><span style="margin-bottom:0pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0.05pt 0pt 0.05pt 0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:12.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> 816</p></td></tr><tr><td style="vertical-align:bottom;width:65.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0.05pt 0pt 0.05pt 0pt;">Provision for warranties during the period</p></td><td style="vertical-align:middle;white-space:nowrap;width:2.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0.05pt 0pt 0.05pt 0pt;"><span style="margin-bottom:0pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0.05pt 0pt 0.05pt 0pt;"><span style="margin-bottom:0pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.9%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> 104</p></td><td style="vertical-align:middle;white-space:nowrap;width:2.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0.05pt 0pt 0.05pt 0pt;"><span style="margin-bottom:0pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0.05pt 0pt 0.05pt 0pt;"><span style="margin-bottom:0pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> 3,296</p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:65.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0.05pt 0pt 0.05pt 0pt;">Settlements made during the period</p></td><td style="background-color:#cceeff;vertical-align:middle;white-space:nowrap;width:2.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0.05pt 0pt 0.05pt 0pt;"><span style="margin-bottom:0pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0.05pt 0pt 0.05pt 0pt;"><span style="margin-bottom:0pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:12.9%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"> (1,211)</p></td><td style="background-color:#cceeff;vertical-align:middle;white-space:nowrap;width:2.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0.05pt 0pt 0.05pt 0pt;"><span style="margin-bottom:0pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0.05pt 0pt 0.05pt 0pt;"><span style="margin-bottom:0pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:12.05%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"> (1,915)</p></td></tr><tr><td style="vertical-align:bottom;width:65.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0.05pt 0pt 0.05pt 0pt;">Balance at end of the year</p></td><td style="vertical-align:middle;white-space:nowrap;width:2.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0.05pt 0pt 0.05pt 0pt;"><span style="margin-bottom:0pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.69%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0.05pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.9%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> 1,090</p></td><td style="vertical-align:middle;white-space:nowrap;width:2.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0.05pt 0pt 0.05pt 0pt;"><span style="margin-bottom:0pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.69%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0.05pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.05%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> 2,197</p></td></tr></table>
sens Product Warranty Term
ProductWarrantyTerm
P1Y
CY2020Q3 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
1100000
CY2019Q4 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
2200000
CY2019Q4 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
2197000
CY2018Q4 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
816000
CY2020Q3 sens Number Of Geographical Markets
NumberOfGeographicalMarkets
2
us-gaap Standard Product Warranty Accrual Warranties Issued
StandardProductWarrantyAccrualWarrantiesIssued
104000
CY2019Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
0
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
172215804
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
101119640
CY2020Q3 sens Accrued Employee Termination Benefits
AccruedEmployeeTerminationBenefits
1400000
CY2019Q4 us-gaap Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
179000
CY2020Q3 sens Prepaid Information Technology And Software Costs Current
PrepaidInformationTechnologyAndSoftwareCostsCurrent
65000
CY2019Q4 sens Prepaid Information Technology And Software Costs Current
PrepaidInformationTechnologyAndSoftwareCostsCurrent
294000
CY2019Q4 us-gaap Prepaid Advertising
PrepaidAdvertising
605000
CY2020Q3 us-gaap Prepaid Rent
PrepaidRent
102000
CY2019Q4 us-gaap Interest Receivable Current
InterestReceivableCurrent
107000
CY2020Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
4588000
CY2019Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
4512000
CY2020Q3 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
259000
CY2019Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
3944000
CY2020Q3 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
1419000
CY2019Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
10938000
CY2020Q3 us-gaap Inventory Raw Materials And Supplies Net Of Reserves
InventoryRawMaterialsAndSuppliesNetOfReserves
2606000
CY2019Q4 us-gaap Inventory Raw Materials And Supplies Net Of Reserves
InventoryRawMaterialsAndSuppliesNetOfReserves
2047000
CY2020Q3 us-gaap Inventory Net
InventoryNet
4284000
CY2019Q4 us-gaap Inventory Net
InventoryNet
16929000
CY2020Q3 us-gaap Inventory Adjustments
InventoryAdjustments
15100000
CY2019Q3 us-gaap Inventory Adjustments
InventoryAdjustments
3300000
CY2020Q3 sens Prepaid Contract Manufacturing Current
PrepaidContractManufacturingCurrent
3649000
CY2019Q4 sens Prepaid Contract Manufacturing Current
PrepaidContractManufacturingCurrent
3043000
CY2020Q3 us-gaap Prepaid Insurance
PrepaidInsurance
442000
CY2019Q4 us-gaap Prepaid Insurance
PrepaidInsurance
44000
CY2020Q3 sens Prepaid Clinical And Preclinical Costs
PrepaidClinicalAndPreclinicalCosts
178000
CY2019Q4 sens Prepaid Clinical And Preclinical Costs
PrepaidClinicalAndPreclinicalCosts
240000
CY2020Q3 us-gaap Prepaid Advertising
PrepaidAdvertising
127000
CY2020Q3 us-gaap Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
25000
CY2020Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
3505000
CY2019Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
5630000
CY2020Q3 us-gaap Interest Payable Current
InterestPayableCurrent
1275000
CY2019Q4 us-gaap Interest Payable Current
InterestPayableCurrent
2153000
CY2020Q3 us-gaap Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
1089000
CY2019Q4 us-gaap Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
2197000
CY2020Q3 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
947000
CY2019Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
1384000
CY2020Q3 sens Accrued Research And Development Current
AccruedResearchAndDevelopmentCurrent
815000
CY2019Q4 sens Accrued Research And Development Current
AccruedResearchAndDevelopmentCurrent
1956000
CY2020Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
769000
CY2019Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
696000
CY2020Q3 sens Accrued Contract Manufacturing Costs Current
AccruedContractManufacturingCostsCurrent
352000
CY2019Q4 sens Accrued Contract Manufacturing Costs Current
AccruedContractManufacturingCostsCurrent
2452000
CY2020Q3 sens Accrued Patient Access And Incentive Programs Current
AccruedPatientAccessAndIncentiveProgramsCurrent
232000
CY2019Q4 sens Accrued Patient Access And Incentive Programs Current
AccruedPatientAccessAndIncentiveProgramsCurrent
1578000
CY2020Q3 us-gaap Accrued Marketing Costs Current
AccruedMarketingCostsCurrent
116000
CY2019Q4 us-gaap Accrued Marketing Costs Current
AccruedMarketingCostsCurrent
553000
CY2020Q3 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
53000
CY2019Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
37000
CY2020Q3 sens Accrued Liabilities And Other Liabilities Current
AccruedLiabilitiesAndOtherLiabilitiesCurrent
9153000
CY2019Q4 sens Accrued Liabilities And Other Liabilities Current
AccruedLiabilitiesAndOtherLiabilitiesCurrent
18636000
CY2020Q3 us-gaap Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
4800000
CY2020Q3 us-gaap Interest Expense Debt Excluding Amortization
InterestExpenseDebtExcludingAmortization
1765000
CY2020Q3 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
1807000
CY2020Q3 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
60000
CY2020Q3 us-gaap Interest Expense Debt
InterestExpenseDebt
3632000
us-gaap Interest Expense Debt Excluding Amortization
InterestExpenseDebtExcludingAmortization
5694000
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
5722000
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
141000
us-gaap Interest Expense Debt
InterestExpenseDebt
11557000
CY2020Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Next Twelve Months
LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
4226000
CY2020Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
1537000
CY2020Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
23811000
CY2020Q3 sens Long Term Debt Maturities Repayments Of Principal After Year Four
LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFour
92700000
CY2020Q3 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
122274000
CY2020Q3 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
0
us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
175289
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
100000
CY2020Q3 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
100000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2019Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2020Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2019Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2020Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2020Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
450000000
CY2020Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
900000000

Files In Submission

Name View Source Status
0001558370-20-013382-index-headers.html Edgar Link pending
0001558370-20-013382-index.html Edgar Link pending
0001558370-20-013382.txt Edgar Link pending
0001558370-20-013382-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
sens-20200930.xsd Edgar Link pending
sens-20200930x10q.htm Edgar Link pending
sens-20200930x10q_htm.xml Edgar Link completed
sens-20200930xex10d1.htm Edgar Link pending
sens-20200930xex31d1.htm Edgar Link pending
sens-20200930xex31d2.htm Edgar Link pending
sens-20200930xex32d1.htm Edgar Link pending
sens-20200930_cal.xml Edgar Link unprocessable
sens-20200930_def.xml Edgar Link unprocessable
sens-20200930_lab.xml Edgar Link unprocessable
sens-20200930_pre.xml Edgar Link unprocessable
Show.js Edgar Link pending